羟氨

Results Chloramine T method is an effective, simplified and accurate assay for determination of hydroxyproline content [(10 93±2 89)μg/g].

结果 氯胺 T法检测羟脯氨酸，方法简便，准确性高，经测定组织工程心脏瓣叶羟脯氨酸含量为(10 93± 2 89)μg/g。

After four weeks, the fluoride levels in the femora and teeth of fluoride treated group were ten times higher than that of the control group.

尿羟脯氨酸、血清羟脯氨酸含量实验前后两组间未见显著差异，4周后实验组骨和牙氟含量比对照组高十几倍。

Three antioxidative parameters(SOD super oxide dismutase、MDA malondialdehyde and GSH reduced glutathione hormone)were also measured.Results:The skin elasticity and water content improved increasingly according to the MPA measurements of the two group 4 weeks after the last irradiation.The hydroxyproline of the skin in the Q-switched 1064-nm Nd:YAG laser of 0.6J/cm~2、1.5 J/cm~2 and 2.5 J/cm~2 group showed 7.1%,13.1%and 19.8%(p＜0.05)increase respectively compared to their controls,the enhancement of dermal thickness were 15.5%,29.7%and 38.4%;The hydroxyproline of the skin in the Q-switched 532-nm Nd:YAG laser of 0.5J/cm~2、1.2 J/cm~2 and 2.0 J/cm~2 group showed 6.9%,9.6%and 14.2%(p＜0.05)increase respectively compared to their controls,the enhancement of dermal thickness were 5.5%,15.1%and 29.9%,among which the Q-switched 1064-nm laser group had the greatest effect. The result of antioxidative parameters showed some juvenescence change at the radiated skin.

结果：末次照射后第4周，Q开关1064-nmNd：YAG激光组(以下简称1064 nm组)和Q开关532-nmNd：YAG激光组(以下简称532-nm组)大鼠各实验侧的皮肤弹性和含水量都明显好于对照侧；1064-nm组和532-nm组实验侧的皮肤羟脯氨酸含量和真皮内胶原厚度都较对照组显著增大(P＜0.05)，其中1064-nm组的三种不同能量密度：0.6 J/cm~2、1.5 J/cm~2、2.5 J/cm~2的激光照射的皮肤区域的羟脯氨酸含量增加率为7.1%，13.1%和19.8%，真皮厚度增加率为15.5%，29.7%和38.4%，532-nm组的三种不同能量密度：0.5 J/cm~2、1.2 J/cm~2、2.0J/cm~2的激光照射的皮肤区域的羟脯氨酸含量增加率为6.9%，9.6%和14.2%，真皮层厚度增加率为5.5%，15.1%和29.9%，相比而言1064-nm组的羟脯氨酸及真皮层厚度增加率均较高；抗氧化指标显示两组大鼠实验侧皮肤的抗氧化能力增加，呈年轻化改变。

Acylamino compounds from AD were synthesized by cleavage of A-ring through NaIO4/KMnO4 oxidation, ring closure by amination, oximation with hydroxylaminechloride in C-17 position, and reduction of oxime in C-17 position and substitution with substituted acylchloride and carboxylic acids.

本文以AD为起始原料，经过NaIO4/KMnO4氧化裂解、胺解环合、羟氨肟化反应，在甾体17位形成肟，并将肟还原成胺，与取代酰氯和有机羧酸反应，合成了15个酰胺化合物。

To observe the changes of pathology and contents of hydroxyproline, total antioxidizing capability, total superoxide dismutase and malondialdehyde in kidneys of unilateral ureteral obstruction rats, and investigate the function of oxidation stress reaction in renal interstitial fibrosis.

目的 采用单侧输尿管结扎致肾间质纤维化大鼠模型，观察UUO后肾脏病理和肾组织在羟氨酸含量及各氧化应激指标的改变，探讨氧化应激在肾间质纤维化中的作用。

Objective To study the relative bioavailability of cefadroxil dispersible tablet and granule.

目的研究头孢羟氨苄分散片与颗粒剂的相对生物利用度。

Water, C12-20 acid PEG-8 ester, hydrogenated polysobutene, petrolatum, dicaprylyl maleate, hydrogenated vegetable oil, propylene glycol, acetylated lancolin, glycoprrotiens,panax ginseng root extract,equisetum arvense extract, carbomer, butyrospermum parkill fruit, potassium cetyl phosphate, triethanolamine, hypericum perforatum extract, malva sylvestris extract, methylparaben, glycerin, urea, saccharide hydrolysate, magnesium aspartate, glycine, alanine, creatine, propylparaben, ethlparaben, imidazolidinyl urea, polyperfluoromethylisopropyl ether, fragrance

水，C12-20 酸 PEG-8酯，氢化聚异丁烯，凡士林，马来酸二辛酯，氢化植物油，丙二醇，乙醯化羊毛脂，糖蛋白，人参根萃取，问荆萃取，卡波姆，乳木果，鲸蜡醇磷酸酯钾，三乙醇胺，金丝桃萃取，锦葵萃取，羟苯甲酯，甘油，尿素，水解糖，天门冬酸镁，甘氨酸，丙氨酸，肌酸，羟苯丙酯，羟苯乙酯，尿素醛，聚全氟甲基异丙基醚，香料

Objective To establish the determination method of cefadroxil in healthy volunteers plasma. Methods Plasma protein was precipitated by perchloric acid (10%), and paraaminobenzoic acid was used as internal standard.

目的 建立用内标法测定人血浆中头孢羟氨苄浓度的HPLC-UV方法方法用10％高氯酸直接沉淀血浆蛋白，以对氨基苯甲酸内标，测定血浆中头孢羟氨苄的浓度。

The effects and mechanism of GABAergic neurons, NOergic neurons, opioid peptide and cyclic adenosine monophosphate in the nucleus reticularis thalami on sleep-wakefulness cycle of rats and the effects and mechanism of the 5-HTergic nerve fibers project from the nucleus raphes dorsalis to RT on sleep-wakefulness cycle of rats were investigated with the methods of brain stereotaxic, nucleus spile, microinjection and polysomngraphy.1. The effects of GABAergic neurons in RT on sleep-wakefulness cycle of rats1.1 Microinjection of 3-mercaptopropionic acid (3-MP, a kind of glutamate decarboxylase inhibitor) into RT. On the day of microinjection, sleep only decreased a litter. On the second day, sleep marked decreased and wakefulness marked increased. On the third and fourth day, sleep and wakefulness stages resumed to normal.1.2 Microinjection of gamma-amino butyric acid (GABA 1.0μg) into RT enhanced sleep and reduced wakefulness compared with control; while microinjection of L-glutamate (L-Glu, 0.2μg) decreased sleep and increased wakefulness; microinjection of bicuculline (BIC, 1.0μg), a GABAA receptor antagonist, enhanced wakefulness and reduced sleep; microinjection of baclofen (BAC, 1.0μg), GABAB receptor agonist, had the same effects as GABA.2. The effects of NOergic neurons in RT on sleep-wakefulness cycle of rats2.1 Microinjection of L-arginine (L-Arg, 0.5μg) into RT decreased sleep compared with control, but there were on statistaical difference between L-Arg group and control; while microinjection of sodium nitroprusside (SNP, 0.2μg), a NO donor into RT, sleep marked decreased and wakefulness marked increased. Microinjection of nitric oxide synthase inhibitor, N-nitro-L-arginine (L-NNA, 2.0μg) into RT enhanced sleep and reduced wakefulness.2.2 After simultaneous microinjection of L-NNA (2.0μg) and SNP (0.2μg) into RT, SNP abolished the sleep-promoting effect of L-NNA compared with L-NNA group; after simultaneous microinjection of L-NNA (2.0μg) and L-Arg(0.5μg) into RT, we found that L-NNA could not blocked the wakefulness-promoting effect of L-Arg.3. The effects of opioid peptide in RT on sleep-wakefulness cycle of rats3.1 Microinjection of morphine sulfate (MOR, 1.0μg) into RT increased wakefulness and decreased sleep compared with control; while microinjection of naloxone hydrochloride (NAL, 1.0μg), the antagonist of opiate receptors, into RT, enhanced sleep and reduced wakefulness.3.2 After simultaneous microinjection of MOR (1.0μg) and NAL (1.0μg) into RT, the wakefulness-promoting effect of MOR and the sleep-promoting effect of NAL were not observed compared with control.4. The effects of cAMP in RT on sleep-wakefulness cycle of rats Microinjection of cAMP (1.0μg) into RT increased sleep and decreased wakefulness compared with control; microinjection of methylene blue (MB,1.0μg) into RT enhanced sleep and reduced wakefulness compared with control.5. The effects of the 5-HTergic nerve fibers project from DRN to RT on sleep-wakefulness cycle of rats5.1 When L-Glu (0.2μg) was microinjected into DRN and normal sodium (NS,1.0μg) was microinjected into bilateral RT. We found that sleep was decreased and wakefulness was increased compared with control; when L-Glu (0.2μg) was microinjected into DRN and methysergide (MS,1.0μg), a non-selective 5-HT antagonist, was microinjected into bilateral RT, We found that sleep was enhanced and wakefulness was reduced compared with L-Glu group.5.2 When p-chlorophenylalanine (PCPA, 10μg) was microinjected into DRN and NS (1.0μg) was microinjected into bilateral RT, We found that sleep was increased and wakefulness was decreased compared with control; microinjection of 5-hydroxytryptaphan (5-HTP, 1.0μg), which can convert to 5-HT by the enzyme tryptophane hydroxylase and enhance 5-HT into bilateral RT, could block the effect of microinjection of PCPA into DRN on sleep-wakefulness cycle.

本研究采用脑立体定位、核团插管、微量注射、多导睡眠描记等方法，研究丘脑网状核(nucleus reticularis thalami，RT)中γ-氨基丁酸(gamma-amino butyric acid ，GABA)能神经元、一氧化氮(nitrogen monoxidum，NO)能神经元、阿片肽类神经递质、环一磷酸腺苷(cyclic adenosine monophosphate，cAMP)及中缝背核(nucleus raphes dorsalis，DRN)至RT的5-羟色胺(5-hydroxytryptamine，5-HT)能神经纤维投射对大鼠睡眠-觉醒周期的影响及其作用机制。1 RT内GABA能神经元对大鼠睡眠-觉醒周期的影响1.1大鼠RT内微量注射GABA合成关键酶抑制剂3-巯基丙酸(3-MP，5μg)，注射当天睡眠时间略有减少，第二日睡眠时间显著减少，觉醒时间明显增多，第三、四日睡眠和觉醒时间逐渐恢复至正常。1.2大鼠RT内微量注射GABA受体激动剂GABA( 1.0μg)后，与生理盐水组比较，睡眠时间增加，觉醒时间减少；而RT内微量注射L-谷氨酸(glutamic acid， L-Glu， 0.2μg)后，睡眠时间减少，觉醒时间增加；RT内微量注射GABAA受体阻断剂荷包牡丹碱(bicuculline，BIC，1.0μg)后，睡眠时间减少，觉醒时间增加；RT内微量注射GABAB受体激动剂氯苯氨丁酸(baclofen，BAC，1.0μg)后，产生了与GABA相似的促睡眠效果。2 RT内NO能神经元对大鼠睡眠-觉醒周期的影响2.1大鼠RT内微量注射NO的前体L-精氨酸(L-Arg，0.5μg)后，与生理盐水组对比，睡眠时间略有减少，但无显著性意义；而RT内微量注射NO的供体硝普钠(Sodium Nitroprusside，SNP，0.2μg)后可明显增加觉醒时间，缩短睡眠时间；微量注射一氧化氮合酶抑制剂L-硝基精氨酸(L-arginine，L-NNA，2.0μg)后，引起睡眠时间增多，觉醒时间减少。2.2大鼠RT内同时微量注射L-NNA(2.0μg)和SNP(0.2μg)后与L-NNA组比较发现SNP逆转了L-NNA的促睡眠作用；RT内同时微量注射L-NNA(2.0μg)和L-Arg(0.5μg)后，与L-NNA(2.0μg)组比较发现L-Arg可以增加觉醒而缩短睡眠，其促觉醒作用未能被NOS的抑制剂L-NNA所逆转。3 RT内阿片肽对大鼠睡眠-觉醒周期的影响3.1大鼠RT内微量注射硫酸吗啡(morphine sulfate，MOR，1.0μg)后与生理盐水组对比，睡眠时间减少而觉醒时间增加； RT内微量注射阿片肽受体拮抗剂盐酸纳洛酮(naloxone hydrochloride，NAL，1.0μg)后与生理盐水组比较，睡眠时间增加而觉醒时间减少。3.2大鼠RT内同时微量注射MOR(1.0μg)和NAL(1.0μg)后，与生理盐水组对比，原有的MOR促觉醒效果和NAL的促睡眠效果都没有表现。4 RT内环一磷酸腺苷信使对大鼠睡眠-觉醒周期的影响大鼠RT内微量注射cAMP(1.0μg)后与NS(1.0μg)组比较，睡眠时间增多而觉醒时间减少；RT内微量注射亚甲蓝(methylene blue，MB，1.0μg)后，与NS组比较，睡眠时间增多而觉醒时间减少。5中缝背核投射到丘脑网状核的5-羟色胺能神经纤维对大鼠睡眠-觉醒周期的影响5.1大鼠DRN内微量注射L-Glu(0.2μg)，同时在双侧RT内微量注射NS (1.0μg)后，与对照组(DRN和双侧RT注射NS， 0.2μg)比较，睡眠时间减少，觉醒时间增多；大鼠DRN内微量注射L-Glu(0.2μg)，同时在双侧RT内微量注射二甲基麦角新碱(methysergide， MS， 1.0μg )后，与对照组(DRN注射L-Glu 0.2μg，双侧RT注射NS 1.0μg)比较，睡眠时间增多，觉醒时间减少。5.2大鼠DRN内微量注射对氯苯丙氨酸(p-chlorophenylalanine，PCPA，10μg)，同时在双侧RT内微量注射NS (1.0μg)后，与对照组(DRN和双侧RT注射NS， 1.0μg)比较，睡眠时间增多，觉醒时间减少；大鼠DRN内微量注射PCPA(10μg)，产生睡眠增多效应后，在双侧RT内微量注射5-羟色胺酸(5-hydroxytryptaphan ， 5-HTP， 1.0μg )后，与对照组(DRN注射PCPA 10μg，双侧RT注射NS 1.0μg)比较，睡眠时间减少，觉醒时间增多。

Systematic experiments were conducted for both water soluble and non-water soluble drugs on this apparatus. Paracetamol, cefadroxil, tetracycline hydrochloride and compound preparation for hepatitis were selected for water soluble drugs while erythromycin and griseofulvin were selected for non-water soluble drugs.

利用该实验装置分别对扑热息痛、头孢羟氨苄、盐酸四环素及复方肝炎制剂等水溶性药物和红霉素及灰黄霉素等非水溶性药物进行了系统的实验研究，考察了溶剂类型和过程操作参数包括混合器压力和温度、溶液浓度、进液速率及沉淀器温度对微粒形态、粒径及粒径分布的影响规律。

This one mode pays close attention to network credence foundation of the businessman very much.

这一模式非常关注商人的网络信用基础。

Cell morphology of bacterial ghost of Pasteurella multocida was observed by scanning electron microscopy and inactivation ratio was estimated by CFU analysi.

扫描电镜观察多杀性巴氏杆菌细菌幽灵和菌落形成单位评价遗传灭活率。